Todd Harrison Discusses Biopharmaceutical Investments
By Bloomberg
28/06/18·1h 20m
Bloomberg Opinion columnist Barry Ritholtz interviews Todd Harrison, a founding partner and chief investment officer at the hedge fund CB1 Capital, which focuses on cannabinoid-based solutions and biopharmaceutical applications and therapies. Prior to his work with CB1 Capital, Harrison spent almost three decades on Wall Street managing risk and researching financial market strategies. He was also the
founder and CEO of Minyanville Media Inc., an Emmy-winning financial media company covering global markets in real time.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com